GCG and diabetes mellitus: Fourth, comparative studies evaluating GLP-1 RAs against other antidiabetic medications (e.g., Metformin) in terms of clinical outcomes, mechanistic pathways, and safety profiles—especially for patients with concurrent diabetes and KOA—represent a critical area for future investigation.